Telegram: Share Web Page

https://invesbrain.com/us-sees-spike-in-paxlovid-usage-as-mercks-molnupiravir-and-astrazenecas-evusheld-are-slower-off-the-shelf/

US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf